Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Completed Secondary Placing

9 Apr 2014 13:52

RNS Number : 4068E
Quixant PLC
09 April 2014
 



9 April 2014

Quixant Plc

("Quixant" or the "Company")

 

£25m placing of 17,857,143 existing Ordinary Shares

 

Quixant (AIM:QXT) a leading provider of specialised computing platforms for casino gaming machine applications, is pleased to announce that in order to satisfy market demand and broaden the institutional shareholder base of the Company, finnCap, as the Company's broker, have conducted an oversubscribed placing of 17,857,143 existing ordinary shares of 0.01p in the Company (the "Placing Shares" and the "Placing") with new and existing institutional investors.

 

The Placing Shares have been sold on behalf of certain directors of the Company and their connected persons (the "Director Vendors") and certain other founder shareholders of the Company (the "Vendor Shareholders"). The Placing Shares were sold at a price of 140 pence per share and represent, in aggregate, 27.6 per cent. of the issued share capital of Quixant.

 

The Director Vendors have been released by finnCap from the terms of their respective lock-in obligations, as set out in paragraph 15 of Part II of the Company's Admission Document dated 21 May 2013 (the "Admission Document") to the extent of the Placing Shares sold in the Placing. All ordinary shares held by the Director Vendors subsequent to the Placing will remain subject to the lock-in obligations and orderly market arrangements set out in the Admission Document. All ordinary shares held by the Vendor Shareholders subsequent to the Placing remain subject to the orderly marketing arrangements set out in paragraph 15 of Part II of the Admission Document.

 

Subsequent to the Placing, the Director Vendors revised shareholdings are set out below.

 

Director

Placing Shares sold

Resultant shareholding

 

Number of Ordinary Shares

% of issued share capital

Number of Ordinary Shares

% of Enlarged Share Capital

Nick Jarmany

8,109,347

12.5%

16,752,923(1)

25.9%

Gary Mullins

3,142,173

4.9%

4,058,641(2)

6.3%

Chen Tai Lin

2,221,739

3.4%

4,589,842(3)

7.1%

 

(1) Mr Jarmany's holding includes 5,573,379 Ordinary Shares, representing 8.6 per cent. of the issued share capital of the Company, registered in the name of his wife, Francesca Marzilli.

 

(2) Mr Mullins' holding includes 389,233 Ordinary Shares, representing 0.6 per cent. of the issued share capital of the Company, registered in the name of his wife, Sophie Jayne Mullins

 

(3) Mr Lin's holding includes 1,167,700 Ordinary Shares, representing 1.8 per cent. of the issued share capital of the Company, registered in the name of his wife, Shu-Hsiang Wu.

 

Subsequent to the Placing the Founder Shareholders revised shareholdings are set out below.

 

Vendor Shareholder

Placing Shares sold

Resultant shareholding

 

Number of Ordinary Shares

% of issued share capital

Number of Ordinary Shares

% of Enlarged Share Capital

Alex Taylor

1,269,565

2.0%

2,662,767

4.1%

Mark Mullins

2,380,434

3.7%

2,484,981

3.8%

Daniel Jarmany

407,714

0.6%

842,286

1.3%

Tim Moulson

326,171

0.5%

673,829

1.0%

 

Nick Jarmany, CEO of Quixant, commented: "Since our IPO in May last year it became increasingly clear to us that greater liquidity was necessary for the long term benefit of the Company. By successfully completing this Placing we have satisfied significant institutional demand and broadened our shareholder base. I am very pleased with the calibre and support of existing and new shareholders and look forward to continuing to implement our growth strategy."

 

Enquiries

 

Quixant plc

Nick Jarmany (Chief Executive)
Jon Jayal (General Manager)

+44(0)1223 892 696

 

Nominated Adviser and Broker:

finnCap Limited

Matt Goode (Corporate Finance)

Charlotte Stranner (Corporate Finance)

Victoria Bates (Corporate Broking)

 

 

+44(0)20 7220 0500

Financial PR:

Newgate Threadneedle

John Coles / Fiona Conroy / Hilary Millar

 

+44(0)20 7653 9850

 

 

About Quixant

Quixant, founded in 2005, designs and manufactures complete advanced hardware and software solutions (Gaming Platforms) for the pay-for-play gaming and slot machine industry. The Company is headquartered outside of Cambridge in the UK. Quixant UK Ltd is responsible for the group's global (excluding North America) sales function and its Las Vegas based subsidiary, Quixant USA Inc, is responsible for sales and sales support to the North American market. Quixant has its own manufacturing and engineering operation in Taiwan, which has evolved with the rapid growth of the Company. Quixant's Italian subsidiary, Quixant Italia, houses the Group's software engineering and customer support team.

 

Quixant's high quality, specialised products provide an all-in-one solution, based on PC technology but with augmentative hardware features and operating software developed specifically to address the requirements of the gaming industry. Products feature innovative mechanical designs which are optimised for operation in the gaming and slot machine environment. Quixant's proprietary hardware and embedded software is flexible in its design, enabling Quixant to easily respond to changes in regulation or customers operating in different markets or jurisdictions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUGUAWCUPCUQB
Date   Source Headline
11th Jun 20193:00 pmRNSHolding(s) in Company
21st May 20194:39 pmRNSHolding(s) in Company
3rd May 201911:07 amRNSDirector/PDMR Shareholding
1st May 20194:09 pmRNSGrant of Options
1st May 20194:03 pmRNSExercise of Options
18th Apr 20194:49 pmRNSExercise of Options
16th Apr 201911:13 amRNSResult of AGM
10th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:57 pmRNSGrant of Options
4th Apr 20191:54 pmRNSGrant of Options
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results
24th Jan 20197:00 amRNSTrading Update and Notice of Results
21st Jan 20192:51 pmRNSHolding(s) in Company
4th Jan 201910:13 amRNSBoard Change
22nd Oct 20189:41 amRNSIssue of Equity & PDMR Dealing
5th Oct 20185:50 pmRNSIssue of Options & Director/PDMR Dealings
21st Sep 20187:40 amRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
19th Jul 20187:00 amRNSTrading Update and Notice of Results
4th Jul 20184:36 pmRNSDirector/PDMR Shareholding
14th May 20188:07 amRNSHolding(s) in Company
11th May 20184:10 pmRNSDirector/PDMR Dealings
30th Apr 20187:00 amRNSDirector/PDMR Shareholdings
27th Apr 20182:15 pmRNSResult of placing in Quixant plc
27th Apr 20189:50 amRNSProposed placing in Quixant plc
24th Apr 201811:14 amRNSResult of AGM
5th Apr 20183:23 pmRNSGrant of Options
26th Mar 20184:18 pmRNSDividend Timetable
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSBoard Changes and Appointment of CFO
2nd Feb 201810:08 amRNSHolding(s) in Company
25th Jan 20187:00 amRNSTrading Update and Notice of Results
28th Nov 20171:59 pmRNSDirector/PDMR Shareholding
27th Oct 20175:15 pmRNSIssue of Equity and Director/PDMR Shareholding
4th Oct 20172:23 pmRNSHolding(s) in Company
21st Sep 20177:03 amRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
11th Sep 20173:00 pmRNSHolding(s) in Company
22nd Aug 201710:16 amRNSHolding(s) in Company
7th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jul 201710:25 amRNSHolding(s) in Company
2nd Jun 20178:00 amRNSDirector/PDMR Shareholding
12th May 20174:55 pmRNSDirector/PDMR Shareholding
4th May 20172:37 pmRNSIssue of Equity and Director/PDMR Dealings
25th Apr 201712:15 pmRNSResult of AGM
22nd Mar 201712:00 pmRNSBoard Appointment
22nd Mar 201710:00 amRNSDividend Timetable
22nd Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.